Your browser is no longer supported. Please, upgrade your browser.
Settings
XBI SPDR S&P Biotech ETF daily Stock Chart
XBI [NYSE]
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.56%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month3.27%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter4.57%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio2.82 Perf Half Y5.02%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year14.91%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range44.04 - 69.19 Perf YTD5.49%
Dividend0.16 P/FCF- EPS past 5Y- ROI- 52W High-9.76% Beta-
Dividend %0.26% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low41.79% ATR1.56
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)47.56 Volatility1.92% 2.61%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.70 Prev Close62.36
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume6.92M Price62.44
Recom- SMA20-0.06% SMA50-1.19% SMA2004.42% Volume4,865,068 Change0.13%
Jan-23-17 02:16PM  Top Biotech Stocks to Buy in 2017 at Motley Fool
Jan-18-17 10:03AM  4 Top Biotech Mutual Funds for 2017
06:00AM  Trump Foreshadows a Bleak Outlook for Biotech at Investopedia
Jan-17-17 11:16AM  Biotech ETFs: When Will The Pain End? at Barrons.com
Jan-16-17 10:55AM  Fidelity Biotech Fund: Better than the Index? at Motley Fool
Jan-12-17 12:01PM  Biotech ETFs Continue To Bleed at Barrons.com
12:00PM  Trump's First Press Conference Puts These ETFs in Focus
11:34AM  Trump's Remarks Show Why Pharma Sector Is 'Barely Investable': More Squawk From Jim Cramer
07:32AM  5 Things You Must Know Before the Market Opens Thursday
06:35AM  Donald Trump Whacks European Stocks
04:47AM  European Pharma Shares Hammered After Trump Press Conference Attack
Jan-11-17 04:27PM  Dow moves within 50 points of 20,000 after Trump news conference at MarketWatch
04:16PM  Nasdaq Posts Another Record Close in Unpredictable Trump-Triggered Trading Session
03:58PM  P.M. Funds Roundup: Mexico, Biotech ETFs Get Trumped; Is It RIP For Bitcoin ETF? at Barrons.com
03:16PM  Stocks Back to Gains in Unsettled Trade After Trump News Conference
02:36PM  Good Enough? Trump Outlines Plans to Separate From Business but Will Not Divest Holdings
02:14PM  Trump Takes Aim at Pharma but Investors Shouldn't Panic
12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes
12:09PM  Biotech, Pharma ETFs Sink; Trump Promises "Bidding Procedures" at Barrons.com
11:30AM  Biotech ETFs fall as Trump says more bidding needed on drugs at MarketWatch
Jan-09-17 09:06AM  How Was Incytes Profitability in 3Q16?
Jan-06-17 12:27PM  The 'Super Bowl' for health care investors
09:07AM  What Were Incytes Revenue Streams in 3Q16?
03:26AM  These stock-market sectors will be the most volatile in 2017: Goldman Sachs at MarketWatch
Jan-05-17 01:25PM  Biotech Stocks Find Reprieve in Options at The Wall Street Journal
Dec-29-16 07:36AM  United Therapeutics Robust Research Pipeline
Dec-28-16 07:02PM  Zacks Podcast Highlights: Immunotherapy Stocks 101: What Biotech Investors Need to Know Now
10:55AM  Celgene Winding Up for 2017 Breakout (CELG, IBB) at Investopedia
Dec-23-16 08:59AM  Your first trade for Friday, December 23 at CNBC
Dec-22-16 05:59PM  Final Trade: F, WTW & more
Dec-16-16 11:07AM  6 Best ETFs For When You're Both Bullish And Cautious About The Markets
Dec-14-16 10:18AM  These Charts Suggest Now Is the Time to Buy Biotech (SRPT) at Investopedia
06:33AM  How to play health care stocks under Trump: Pro
06:30AM  Can Trump keep promise to reduce drug prices?
Dec-12-16 07:32AM  Traders bet on floor in biotech fund
Dec-09-16 04:14PM  Biotech ETFs: A Short-Lived Boon From Biogen at Barrons.com
Dec-08-16 03:00PM  Biotech & Pharma ETFs to Suffer in 2017 Too?
11:27AM  3 Reasons To Shrug Off Trump's Rhetoric On Drug Prices at Barrons.com
10:44AM  Why Biotech is Getting KilledAnd Why It WIll Bounce Back at Barrons.com
Dec-07-16 05:00PM  Bad Day for Biotechs Means It's Time to Buy
04:28PM  Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers
04:06PM  Dow Scores Another Record for Third Consecutive Day; S&P 500 Also Hits New High
02:46PM  Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally
02:11PM  President-elect Trumps promise to bring down drug prices sends biotech and pharma ETFs slumping at MarketWatch
01:40PM  Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower
12:40PM  Trumps Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares at 24/7 Wall St.
11:35AM  This indicator says the stock markets celebration has gone too far at MarketWatch
11:31AM  Biotech ETFs: So Much For The Trump Bounce at Barrons.com
11:13AM  Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans
11:03AM  Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall
09:14AM  Trump: I'm Going To Bring Down Drug Prices
08:49AM  President-elect Trump's biotech comments sharply lower biotech ETFs at MarketWatch
Dec-05-16 09:01AM  Here's Why ACADIA Pharmaceuticals Jumped 17.7% in November at Motley Fool
Dec-04-16 06:22PM  Billionaire Rob Citrones Monster Q3 Buys: Kellogg, Macys, Activision-Blizzard, More at Insider Monkey
Dec-02-16 09:21AM  3 Biotech Stocks to Buy in December at Motley Fool
08:44AM  Gundlach warns Trump trade is losing steam and stocks have peaked at MarketWatch
08:04AM  Label Expansion May Boost Venclextas Growth Prospects
08:04AM  What Do Analysts Recommend for Gilead Sciences Stock?
Dec-01-16 12:15PM  Nelson: Optimistic about innovation possibly impacting ca...
11:05AM  Valbenazine May Become a Leading Therapy for Tardive Dyskinesia
08:51AM  Five ways to evaluate an Obamacare replacement plan at MarketWatch
08:50AM  What to expect from HHS Secretary nominee and Obamacare opponent Tom Price at MarketWatch
08:06AM  Why AbbVie Wants to Develop Anti-Tau Therapies
Nov-29-16 05:04PM  Next-Generation Hepatitis C Therapy May Be AbbVies Growth Driver
02:00PM  AbbVies Financial Guidance for 2017
Nov-23-16 10:16AM  Analysts say Juno's stock tumbles shouldn't spill over to Bluebird, Kite Pharma shares at MarketWatch
Nov-22-16 10:08AM  How Stocks and Bonds Reacted to Trumps Victory
Nov-17-16 12:18PM  Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios
08:34AM  Leading Indicator, testing key breakout level!
Nov-16-16 05:22PM  Is Immunotherapy the Next Hot Industry for Biotech Stock Investors?
08:15AM  Biotech takes Trump presidency as a green light and end to drug price worries at MarketWatch
Nov-14-16 10:57AM  5 Reasons to Buy 5 Low P/E Biotech ETFs
Nov-13-16 11:20AM  Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
Nov-11-16 05:05PM  November Surprise Rallies Stocks
Nov-10-16 11:26AM  The death of Obamacare will bring new opportunities for investors at MarketWatch
Nov-09-16 10:58AM  Here's Why Keryx Biopharmaceuticals Fell 18% in October at Motley Fool +10.37%
09:48AM  Drug and Biotech Stocks Rise as Price Clampdown Fears Ease Under Trump Presidency (Updated)
Nov-08-16 11:06AM  Investors Have Dumped Health-Care Stocks, Regardless of the Polls at The Wall Street Journal
09:34AM  Which S&P 500 Sectors Do the Best for an Incumbent Democrat?
Nov-07-16 01:22PM  Biotech ETFs Boosted By Biogen at Barrons.com
10:02AM  Healthcare ETFs in the Spotlight as Election Approaches
Nov-04-16 05:40PM  SPY ETF Tests A Key Level As Every S&P Sector Posts A Weekly Loss
06:45AM  'The Sky Is Literally Falling' -- Health Care Investor Sentiment Sinks to End-Time Lows
Nov-02-16 11:04AM  How Is Kanuma Progressing Globally?
08:15AM  Stock market fear factor rises as Clinton-Trump race tightens at MarketWatch
07:02AM  Allergan's stock gains as $10 billion ASR and new dividend offsets profit and sales miss at MarketWatch
Nov-01-16 03:54PM  Eli Lilly's Stock Price Feels the Bern at The Wall Street Journal
12:46PM  Top ETF Stories of October
11:12AM  October ETF Performance Report
Oct-31-16 06:04PM  Analyst Recommendations for BioMarin after Its 3Q16 Earnings
05:58PM  Final Trade: DVA, UA & more
05:39PM  Can Key Level Stop The Bleeding In Health Care Stocks?
05:01PM  Win-win election plays
11:58AM  Obamacare: Will the Next US President Kill It or Cure It?
Oct-27-16 04:19PM  Amgen beats profit expectations and raises its outlook at MarketWatch
Oct-26-16 12:00PM  Charts Suggest 2017 Will Be the Year of Biotech at Investopedia
10:58AM  Biotech Stocks: Did Trump Video Cost Investors $50 Billion? at Barrons.com
Oct-25-16 06:14AM  [$$] The Next Big Moves in Health-Care Stocks at Barrons.com
Oct-20-16 06:45PM  Major ETFs Fall, But Biotech And Pharma Stocks Defy General Malaise
01:57PM  Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.